World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Switzerland
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
100
Citations
54761
World Ranking
1483
National Ranking
32

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Switzerland Leader Award

Overview

Pascal Schneider is affiliated with the University of Lausanne in Switzerland. Their research primarily spans the fields of biochemistry, genetics and molecular biology, immunology and microbiology, and medicine. Their work involves subfields such as immunology, molecular biology, genetics, cell biology, and hematology.

The scientist's research topics include immune cell function and interaction, T-cell and B-cell immunology, dental development and anomalies, immunodeficiency and autoimmune disorders, chronic lymphocytic leukemia research, cell adhesion molecules research, and proteoglycans and glycosaminoglycans research.

Some of their recent papers include:

  • APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans, 2021, Nature
  • A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS, 2020, The Journal of Experimental Medicine
  • Thy-1 (CD90)-Induced Metastatic Cancer Cell Migration and Invasion Are β3 Integrin-Dependent and Involve a Ca2+/P2X7 Receptor Signaling Axis, 2021, Frontiers in Cell and Developmental Biology
  • Syndecan-4/PAR-3 signaling regulates focal adhesion dynamics in mesenchymal cells, 2020, Cell Communication and Signaling
  • Function, occurrence and inhibition of different forms of BAFF, 2021, Current Opinion in Immunology

Frequent publication venues for their research include:

  • Zenodo (CERN European Organization for Nuclear Research)
  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Cell and Developmental Biology
  • Frontiers in Immunology

Pascal Schneider has collaborated extensively with several researchers, including:

  • Mahya Eslami
  • Cristian R. Smulski
  • Hermann Eibel
  • Laure Willen
  • Lisette Leyton

Best Publications

  • Inhibition of death receptor signals by cellular FLIP

    Martin Irmler;Margot Thome;Michael Hahne;Pascal Schneider

  • Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.

    Nils Holler;Rossana Zaru;Olivier Micheau;Margot Thome

  • Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

    Fabienne Mackay;Stephen A. Woodcock;Pornsri Lawton;Christine Ambrose

  • Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape

    M. Hahne;D. Rimoldi;M. Schröter;P. Romero

  • BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

    Pascal Schneider;Fabienne Mackay;Véronique Steiner;Kay Hofmann

  • Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

    Margot Thome;Pascal Schneider;Kay Hofmann;Helmut Fickenscher

  • Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

    Isabelle Viard;Philippe Wehrli;Roberto Bullani;Pascal Schneider

  • BAFF AND APRIL: a tutorial on B cell survival.

    Fabienne Mackay;Pascal Schneider;Paul Rennert;Jeffrey Browning

  • IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

    James E. Vince;W. Wei-Lynn Wong;Nufail Khan;Rebecca Feltham

  • The molecular architecture of the TNF superfamily

    Jean-Luc Bodmer;Pascal Schneider;Jürg Tschopp

  • BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF

    Jeffrey S. Thompson;Sarah A. Bixler;Fang Qian;Kalpit Vora

  • Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome

    Joanna Groom;Susan L. Kalled;Anne H. Cutler;Carl Olson

  • Cracking the BAFF code

    Fabienne Mackay;Pascal Schneider

  • Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity

    Pascal Schneider;Nils Holler;Jean Luc Bodmer;Michael Hahne

  • BAFF mediates survival of peripheral immature B lymphocytes.

    Marcel Batten;Joanna Groom;Teresa G. Cachero;Fang Qian

  • TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB

    Pascal Schneider;Margot Thome;Kim Burns;Jean-Luc Bodmer

  • TRAIL receptor-2 signals apoptosis through FADD and caspase-8

    Jean-Luc Bodmer;Nils Holler;Séverine Reynard;Patrizia Vinciguerra

  • Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans

    U Salzer;H M Chapel;A D B Webster;Q Pan-Hammarström

  • MyD88, an adapter protein involved in interleukin-1 signaling.

    Kimberly Burns;Fabio Martinon;Christoph Esslinger;Heike Pahl

  • APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth

    Michael Hahne;Takao Kataoka;Michael Schröter;Kay Hofmann

Frequent Co-Authors

Jürg Tschopp
Jürg Tschopp University of Lausanne
Fabienne Mackay
Fabienne Mackay QIMR Berghofer Medical Research Institute
Jeffrey L. Browning
Jeffrey L. Browning Boston University
Aubry Tardivel
Aubry Tardivel University of Lausanne
Christine Ambrose
Christine Ambrose Biogen (United States)
Malcolm J. McConville
Malcolm J. McConville University of Melbourne
Michael A. J. Ferguson
Michael A. J. Ferguson University of Dundee
Kay Hofmann
Kay Hofmann University of Cologne
Michael Hahne
Michael Hahne Centre national de la recherche scientifique, CNRS
Andrew F. G. Quest
Andrew F. G. Quest University of Chile

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Pascal Schneider

Trending Scientists